Cardiorespiratory treatments as modifiers of the relationship between particulate matter and health: A case-only analysis on hospitalized patients in Italy

Environmental Research

Volumn 136, Issue , 2015, Pages 491-499

  Conti, Sara ^a   Lafranconi, Alessandra ^a   Zanobetti, Antonella ^b   Fornari, Carla ^a   Madotto, Fabiana ^a   Schwartz, Joel ^b   Cesana, Giancarlo ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Case only analysis; Effect modification; Particulate matter; Pharmacological treatments

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; THEOPHYLLINE; PARTICULATE MATTER;

CARDIOVASCULAR DISEASE; DISEASE TREATMENT; DRUG; HOSPITAL SECTOR; PARTICULATE MATTER; PUBLIC HEALTH; TOXICOLOGY;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; COLD; COMORBIDITY; FEMALE; HEALTH; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARTICULATE MATTER; PILOT STUDY; SEASON; CARDIOVASCULAR DISEASES; HOSPITAL PATIENT; RESPIRATORY TRACT DISEASES;

ITALY; LOMBARDY;

CARDIOVASCULAR DISEASES; HOSPITALIZATION; HUMANS; INPATIENTS; ITALY; PARTICULATE MATTER; PILOT PROJECTS; RESPIRATORY TRACT DISEASES;

EID: 84911941862     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.09.007     Document Type: Article

References (64)

1. Anderson H.R., Armstrong B., Hajat S., Harrison R., Monk V., Poloniecki J., et al. Air pollution and activation of implantable cardioverter defibrillators in London. Epidemiology 2010, 21:405-413. 10.1097/EDE.0b013e3181d61600.
2. Armstrong B.G. Fixed factors that modify the effects of time-varying factors: applying the case-only approach. Epidemiology 2003, 14:467-472. 10.1097/01.ede.0000071408.39011.99.
3. Baccarelli A., Cassano P.A., Litonjua A., Park S.K., Suh H., Sparrow D., et al. Cardiac autonomic dysfunction: effects from particulate air pollution and protection by dietary methyl nutrients and metabolic polymorphisms. Circulation 2008, 117:1802-1809. 10.1161/circulationaha.107.726067.
4. Bai N., Khazaei M., van Eeden S.F., Laher I. The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction. Pharmacol.Ther. 2007, 113:16-29. 10.1016/j.pharmthera.2006.06.005.
5. Bartoli C.R., Wellenius G.A., Diaz E.A., Lawrence J., Coull B.A., Akiyama I., et al. Mechanisms of inhaled fine particulate air pollution-induced arterial blood pressure changes. Environ. Health Perspect. 2009, 117:361-366. 10.1289/ehp.11573.
6. Bernstein J.A., Alexis N., Barnes C., Bernstein I.L., Nel A., Peden D., et al. Health effects of air pollution. J. Allergy Clin. Immunol. 2004, 114:1116-1123. 10.1016/j.jaci.2004.08.030.
7. Berti G., Chiusolo M., Grechi D., Grosa M., Rognoni M., Tessari R., et al. Environmental indicators in ten Italian cities (2001-2005): the air quality data for epidemiological surveillance. Epidemiol. Prev. 2009, 33:13-26.
8. Biggeri A., Bellini P., Terracini B. Meta-analysis of the Italian studies on short-term effects of air pollution. Epidemiol. Prev. 2001, 25:1-71. Italian Misa Group.
9. Bouthillier L., Vincent R., Goegan P., Adamson I.Y., Bjarnason S., Stewart M., et al. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am. J. Pathol. 1998, 153:1873-1884. 10.1016/s0002-9440(10)65701-x.
10. Brook R.D., Brook J.R., Urch B., Vincent R., Rajagopalan S., Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 2002, 105:1534-1536. 10.1161/01.CIR.0000013838.94747.64.
11. Brook R.D., Rajagopalan S., Pope C.A., Brook J.R., Bhatnagar A., Diez-Roux A.V., et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010, 121:2331-2378. 10.1161/CIR.0b013e3181dbece1.
12. Brown D.M., Donaldson K., Stone V. Effects of PM10 in human peripheral blood monocytes and J774 macrophages. Respir. Res. 2004, 5:29. 10.1186/1465-9921-5-29.
13. Brown D.M., Hutchison L., Donaldson K., Stone V. The effects of PM10 particles and oxidative stress on macrophages and lung epithelial cells: modulating effects of calcium-signaling antagonists. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L1444-L1451. 10.1152/ajplung.00162.2006.
14. Brown J.S., Zeman K.L., Bennett W.D. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. 2002, 166:1240-1247. 10.1164/rccm.200205-399OC.
15. Brunekreef B., Holgate S.T. Air pollution and health. Lancet 2002, 360:1233-1242. 10.1016/S0140-6736(02)11274-8.
16. Chan C.C., Chuang K.J., Shiao G.M., Lin L.Y. Personal exposure to submicrometer particles and heart rate variability in human subjects. Environ. Health Perspect. 2004, 112:1063-1067. 10.1289/ehp.6897.
17. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987, 40:373-383.
18. Delfino R.J., Quintana P.J., Floro J., Gastanaga V.M., Samimi B.S., Kleinman M.T., et al. Association of FEV1 in asthmatic children with personal and microenvironmental exposure to airborne particulate matter. Environ. Health Perspect. 2004, 112:932-941. 10.1289/ehp.6815.
19. Delfino R.J., Zeiger R.S., Seltzer J.M., Street D.H. Symptoms in pediatric asthmatics and air pollution: differences in effects by symptom severity, anti-inflammatory medication use and particulate averaging time. Environ. Health Perspect. 1998, 106:751-761.
20. Dockery D.W. Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ. Health Perspect. 2001, 109(Suppl. 4):S483-S486.
21. Dominici F., Peng R.D., Bell M.L., Pham L., McDermott A., Zeger S.L., et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. J. Am. Med. Assoc. 2006, 295:1127-1134. 10.1001/jama.295.10.1127.
22. Donaldson K., Gilmour M.I., MacNee W. Asthma and PM10. Respir. Res. 2000, 1:12-15. 10.1186/rr5.
23. Donaldson K., Stone V., Seaton A., MacNee W. Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ. Health Perspect. 2001, 109(Suppl. 4):S523-S527.
24. Driscoll K.E., Maurer J.K., Higgins J., Poynter J. Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. J. Toxicol. Environ. Health 1995, 46:155-169. 10.1080/15287399509532026.
25. Faustini A., Stafoggia M., Cappai G., Forastiere F. Short-term effects of air pollution in a cohort of patients with chronic obstructive pulmonary disease. Epidemiology 2012, 23:861-879. 10.1097/EDE.0b013e31826767c2.
26. Fellegi I.P., Sunter A.B. A theory for record linkage. J. Am. Stat. Assoc. 1969, 64:1183-1210. 10.1080/01621459.1969.10501049.
27. Fornari C., Madotto F., Demaria M., Romanelli A., Pepe P., Raciti M., et al. Record-linkage procedures in epidemiology: an Italian multicentre study. Epidemiol. Prev. 2008, 32:79-88.
28. Frampton M.W. Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans. Environ. Health Perspect. 2001, 109(Suppl. 4):S529-S532.
29. Global Initiative for Asthma (GINA). Pocket Guide for Asthma Management and Prevention. 2005.
30. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Pocket Guide to COPD Diagnosis, Management, and Prevention. A Guide for Health Care Professionals. 2005.
31. Gold D.R., Samet J.M. Air pollution, climate, and heart disease. Circulation 2013, 128:e411-e414. 10.1161/circulationaha.113.003988.
32. Gualtieri M., Mantecca P., Corvaja V., Longhin E., Perrone M.G., Bolzacchini E., et al. Winter fine particulate matter from Milan induces morphological and functional alterations in human pulmonary epithelial cells (A549). Toxicol. Lett. 2009, 188:52-62. 10.1016/j.toxlet.2009.03.003.
33. Legge n. 388 23 dicembre, 2000. Disposizioni per la formazione del bilancio annualee pluriennale dello Stato (legge finanziaria 2001). Gazzetta Ufficiale 2000. n. 302 del 29 dicembre 2000 - Supplemento Ordinario n. 219.
34. Legge n. 405 16 novembre, 2001. Conversione in legge, con modificazioni, del decreto-legge 18 settembre 2001, n. 347, recante interventi urgenti in materia di spesa sanitaria. Gazzetta Ufficiale 2001. n. 268 del 17 novembre 2001.
35. Lin L.I.K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989, 45:255-268. 10.2307/2532051.
36. MacNee W., Donaldson K. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur. Respir. J. Suppl. 2003, 40:47s-51s. 10.1183/09031936.03.00403203.
37. Madotto F., Riva M., Fornari C., Scalone L., Ciampichini R., Bonazzi C., et al. Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population. Epidemiol., Biostat. Public Health 2013, 10:e8840-1. (e8840-11). 10.2427/8840.
38. Medina-Ramon M., Schwartz J. Who is more vulnerable to die from ozone air pollution?. Epidemiology 2008, 19:672-679. 10.1097/EDE.0b013e3181773476.
39. Medina-Ramon M., Zanobetti A., Cavanagh D.P., Schwartz J. Extreme temperatures and mortality: assessing effect modification by personal characteristics and specific cause of death in a multi-city case-only analysis. Environ. Health Perspect. 2006, 114:1331-1336. 10.1289/ehp.9074.
40. Medina-Ramon M., Zanobetti A., Schwartz J. The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. Am. J. Epidemiol. 2006, 163:579-588. 10.1093/aje/kwj078.
41. Mills N.L., Donaldson K., Hadoke P.W., Boon N.A., MacNee W., Cassee F.R., et al. Adverse cardiovascular effects of air pollution. Nat. Clin. Pract. Cardiovasc. Med. 2009, 6:36-44. 10.1038/ncpcardio1399.
42. Miyata R., Bai N., Vincent R., Sin D.D., Van Eeden S.F. Novel properties of statins: suppression of the systemic and bone marrow responses induced by exposure to ambient particulate matter (PM(10)) air pollution. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 303:L492-L499. 10.1152/ajplung.00154.2012.
43. Miyata R., Bai N., Vincent R., Sin D.D., Van Eeden S.F. Statins reduce ambient particulate matter-induced lung inflammation by promoting the clearance of particulate matter,<10 mum from lung tissues. Chest 2013, 143:452-460. 10.1378/chest.12-1237.
44. O'Neill M.S., Veves A., Sarnat J.A., Zanobetti A., Gold D.R., Economides P.A., et al. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup. Environ. Med. 2007, 64:373-379. 10.1136/oem.2006.030023.
45. Peters A., Liu E., Verrier R.L., Schwartz J., Gold D.R., Mittleman M., et al. Air pollution and incidence of cardiac arrhythmia. Epidemiology 2000, 11:11-17.
46. Psaty B.M., Koepsell T.D., Lin D., Weiss N.S., Siscovick D.S., Rosendaal F.R., et al. Assessment and control for confounding by indication in observational studies. J. Am. Geriatr. Soc. 1999, 47:749-754.
47. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J.C., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care 2005, 43:1130-1139.
48. Ren C., Park S.K., Vokonas P.S., Sparrow D., Wilker E., Baccarelli A., et al. Air pollution and homocysteine: more evidence that oxidative stress-related genes modify effects of particulate air pollution. Epidemiology 2010, 21:198-206. 10.1097/EDE.0b013e3181cc8bfc.
49. Rhoden C.R., Wellenius G.A., Ghelfi E., Lawrence J., Gonzalez-Flecha B. PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation. Biochim. Biophys. Acta 2005, 1725:305-313. 10.1016/j.bbagen.2005.05.025.
50. Rich K.E., Petkau J., Vedal S., Brauer M. A case-crossover analysis of particulate air pollution and cardiac arrhythmia in patients with implantable cardioverter defibrillators. Inhal. Toxicol. 2004, 16:363-372. 10.1080/08958370490439515.
51. Rückerl R., Greven S., Ljungman P., Aalto P., Antoniades C., Bellander T., et al. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ. Health Perspect. 2007, 115:1072-1080. 10.1289/ehp.10021.
52. Rückerl R., Schneider A., Breitner S., Cyrys J., Peters A. Health effects of particulate air pollution: a review of epidemiological evidence. Inhal. Toxicol. 2011, 23:555-592. 10.3109/08958378.2011.593587.
53. Sakamoto N., Hayashi S., Mukae H., Vincent R., Hogg J.C., van Eeden S.F. Effect of atorvastatin on PM10-induced cytokine production by human alveolar macrophages and bronchial epithelial cells. Int. J. Toxicol. 2009, 28:17-23. 10.1177/1091581809333140.
54. Schwartz J. Who is sensitive to extremes of temperature?: a case-only analysis. Epidemiology 2005, 16:67-72. 10.1097/01.ede.0000147114.25957.71.
55. Schwartz J., Park S.K., O'Neill M.S., Vokonas P.S., Sparrow D., Weiss S., et al. Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction. Am. J. Respir. Crit. Care Med. 2005, 172:1529-1533. 10.1164/rccm.200412-1698OC.
56. Silverman F., Hosein H.R., Corey P., Holton S., Tarlo S.M. Effects of particulate matter exposure and medication use on asthmatics. Arch. Environ. Health 1992, 47:51-56. 10.1080/00039896.1992.9935944.
57. Vedal S., Rich K., Brauer M., White R., Petkau J. Air pollution and cardiac arrhythmias in patients with implantable cardioverter defibrillators. Inhal. Toxicol. 2004, 16:353-362. 10.1080/08958370490439506.
58. von Klot S., Wölke G., Tuch T., Heinrich J., Dockery D.W., Schwartz J., et al. Increased asthma medication use in association with ambient fine and ultrafine particles. Eur. Respir. J. 2002, 20:691-702. 10.1183/09031936.02.01402001.
59. Wellenius G.A., Schwartz J., Mittleman M.A. Particulate air pollution and hospital admissions for congestive heart failure in seven United States cities. Am. J. Cardiol. 2006, 97:404-408. 10.1016/j.amjcard.2005.08.061.
60. Ying Z., Yue P., Xu X., Zhong M., Sun Q., Mikolaj M., et al. Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1540-H1550. 10.1152/ajpheart.01270.2008.
61. Zanobetti A., Schwartz J. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ. Health Perspect. 2005, 113:978-982. 10.1289/ehp.7550.
62. Zanobetti A., Schwartz J. Air pollution and emergency admissions in Boston, MA. J. Epidemiol. Community Health 2006, 60:890-895. 10.1136/jech.2005.039834.
63. Zanobetti A., Schwartz J., Dockery D.W. Airborne particles are a risk factor for hospital admissions for heart and lung disease. Environ. Health Perspect. 2000, 108:1071-1077.
64. Zanobetti A., Stone P.H., Speizer F.E., Schwartz J.D., Coull B.A., Suh H.H., et al. T-wave alternans, air pollution and traffic in high-risk subjects. Am. J. Cardiol. 2009, 104:665-670. 10.1016/j.amjcard.2009.04.046.